Serum Institute of India, which makes the most used COVID-19 vaccine in the country, on Saturday defended pricing Covishield vaccine at 1.5 times the initial rate, saying the earlier price was......
The Serum Institute has disassociated itself from its executive director's statement that the government began the COVID-19 vaccination of multiple age groups without taking into consideration the......
Vaccine makers in India have a limited stockpile of doses, even as COVID-19 threatens to rear its head this winter season, reports Sohini Das. IMAGE: A beneficiary is being inoculated with a......
A probe initiated by the Drugs Controller General of India into an alleged "serious adverse event" reportedly suffered by an Oxford COVID-19 vaccine trial participant in Chennai has found that it......
'We seem to be in a situation where we can do little, and nothing needs to be done anyway.' Photograph: ANI Photo As India's COVID-19 daily case count dips below the 100-mark, approvals for......
A model being considered is to have a combined cold chain approach - where the agricultural cold chain would be combined with vaccine cold chains. As we inch closer to getting a vaccine for......
Young Indian entrepreneurs hope to share some of the limelight too at the Hyderabad event.B Dasarath Reddy reports. New-age entrepreneurs, from Flipkart Executive Chairman Sachin Bansal to......
The western world had largely considered India to be a production hub, and also, a good potential geography for clinical trials, and a big market. But in Covid-19 research, Indian companies and......
'I'll give it to the vaccine manufacturers without guarantees, take the payment in advance and give me the supplies.''The moment you give me one lot of supply, I'll give you more.' IMAGE: A......
Infrastructure conglomerate Lanco Group and leading financial services firm Edelweiss Capital have emerged frontrunners in the race for Axis Bank's private equity arm. According to two people......